Lalezari, Jacob <br/><br/>
Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults.  [electronic resource] 

 -  AIDS (London, England)  Sep 2005 
 - 1443-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/01.aids.0000183633.06580.8a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--adverse effects<br/>Benzoates--adverse effects<br/>CCR5 Receptor Antagonists<br/>Diketopiperazines<br/>Double-Blind Method<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1<br/>Humans<br/>Male<br/>Middle Aged<br/>Piperazines<br/>RNA, Viral--blood<br/>Spiro Compounds--adverse effects<br/>Treatment Outcome